Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Kangyuan Pharmaceutical is a pharmaceutical manufacturing company headquartered in Jingmen, Hubei Province, China. Founded in 2004, the company specializes in the development and production of Traditional Chinese Medicine (TCM) and chemical generic drugs. Its manufacturing capabilities include GMP-certified lines for tablets, capsules, and granules, covering therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health. The company is recognized as a National High-tech Enterprise in China and focuses on the modernization of herbal medicines alongside the production of essential chemical pharmaceuticals. Hubei Kangyuan primarily targets the domestic Chinese market, providing a range of over-the-counter and prescription products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Kangyuan Pharmaceutical.